SPR

Today, Medtronic announced its intent to acquire SPR Therapeutics.

Since our founding, SPR has been focused on expanding access to meaningful, less-invasive pain treatment. As a global healthcare technology leader, Medtronic shares our commitment to advancing pain care and expanding access to meaningful therapies. This planned acquisition will create opportunity to reach more patients, support more clinicians, and help advance earlier intervention.

Until closing, SPR Therapeutics and Medtronic will continue to operate as independent companies. Read the full announcement here: https://news.medtronic.com/2026-05-20-Medtronic-announces-intent-to-acquire-SPR-Therapeutics,-Inc-,-expanding-care-options-for-people-living-with-chronic-pain

For , we're sharing stories from patients like Ben.

Ben, a Marine veteran and entrepreneur, lost his hand after a firework accident. He suffered "excruciating and constant" pain post-amputation. It threatened Ben’s career, his marriage, and his family’s ability to adopt. He knew he needed help.

After going through morphine, drugs that treated nerve pain, and then more opioids, he still had pain, trouble sleeping, and little relief. That is when he was introduced to the System

Read Ben's full : https://www.sprpainrelief.com/patients-caregivers/resources/patient-stories/ben

Most common adverse events are skin irritation & erythema. Results may vary; patient experiences are their own. Rx Only. Important risk & safety information: https://bit.ly/2FU92NH